Skip to main content
SpringerLink
Log in

Hörstörungen

  • Chapter
Medikamentös induzierte neurologische und psychiatrische Störungen

  • 772 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Akyol MU, Sarac S, Akyol G, Atac A, Poyraz A, Belgin E, Turan E (2001) Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea. Otolaryngol Head Neck Surg 124: 107–110

    Article  PubMed  CAS  Google Scholar 

  • Alberts DS, Dahlberg S, Green SJ et al. (1993) Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A southwest oncology group study. Cancer 71(suppl 2): 618–627

    PubMed  CAS  Google Scholar 

  • Alvan G, Karlsson KK, Hellgren U, Villen T (1991) Hearing impariment related to plasma quinine concentration in healthy volunteers. Br J Clin Pharmacol 31: 409–412

    PubMed  CAS  Google Scholar 

  • Aquino VM, Fort DW, Kamen BA (1999) Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study. J Neurooncol 41: 255–259

    Article  PubMed  CAS  Google Scholar 

  • Arnaout MK, Radomski KM, Srivastava DK, Tong X, Belt JR, Raimondi SC, Behm FG, Santana VM, Crom WR, Mirro J, Ribeiro RC (2000) Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short-and long-term effects. Leukemia 14: 1736–1742

    Article  PubMed  CAS  Google Scholar 

  • Arnold W, Nadol JB, Weidauer H (1981) Ultrastructural histopathology in a case of human ototoxicity due to loop diuretics. Acta Otolaryngol 91: 399–414

    PubMed  CAS  Google Scholar 

  • Assietti R, Olson JJ (1996) Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity. J Neurooncol 27: 251–258

    Article  PubMed  CAS  Google Scholar 

  • Agusti C, Ferran F, Gea J, Picado C (1991) Ototoxic reaction to erythromycin. Arch Intern Med 151:380

    Article  PubMed  CAS  Google Scholar 

  • Aydogdu I, Ozturan O, Kuku I, Kaya E, Sevinc A, Yildiz R (2000) Bilateral transient hearing loss associated with vincristine therapy: case report. J Chemother 12: 530–532

    PubMed  CAS  Google Scholar 

  • Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC (1997) A meta-analysis of extended dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 24: 786–795

    PubMed  CAS  Google Scholar 

  • Bailly F, Mattei A, Si Ahmed SN, Trepo C (1997) Sudden deafness induced by interferon-alpha in viral hepatitic C. Gastroenterol Clin Biol 21: 157–158

    PubMed  CAS  Google Scholar 

  • Balm AJ, Rasch CR, Schronagel JH et al. (2004) High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 26: 485–493

    Article  PubMed  Google Scholar 

  • Bates DE, Beaumont SJ, Baylis BW (2002) Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 36: 446–451

    Article  PubMed  Google Scholar 

  • Bauer CA, Brozoski TJ (2005) Cochlear structure and function after round window application of ototoxins. Hear Res 201: 121–131

    Article  PubMed  CAS  Google Scholar 

  • Beminger E, Karlsson KK, Alvan G (1998) Quinine reduces the dynamic range of the human auditory system. Acta Otolaryngol 118: 46–51

    Google Scholar 

  • Bizjak ED, Haug MT, Schilz RJ, Sarodia BD, Dresing JM (1999) Intravenous azithromycin-induced ototoxicity. Pharmacotherapy 19: 245–248

    PubMed  CAS  Google Scholar 

  • Boettcher FA, Salvi RJ (1991) Salicylate ototoxicity: review and synthesis. Am J Otolaryngol 12: 33–47

    PubMed  CAS  Google Scholar 

  • Bokemyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77: 1355–1362

    Google Scholar 

  • Brien JA (1993) Ototoxicity associated with salicylates. A brief review. Drug Saf 9:143–148

    PubMed  CAS  Google Scholar 

  • Brown R, Wise R (1982) Vancomycin: a reappraisal. BMJ 284: 1508–1509

    PubMed  CAS  Google Scholar 

  • Brummett RE (1980) Drug induced ototoxicity. Drugs 19:412–428

    PubMed  CAS  Google Scholar 

  • Brummett RE, Fox KE (1989) Aminoglycoside induced hearing loss in humans. Antimicrob Agents Chemother 33: 797–800

    PubMed  CAS  Google Scholar 

  • Cadoni G, Marinelli L, DeSantis A, Romito A, Manna R, Ottaviani F (1998) Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis. J Laryngol Otol 112: 962–963

    PubMed  CAS  Google Scholar 

  • Casano R, Johnson DF, Bykhovskaya Y, Torricelli F, Bigozzi M, Fischel-Ghodsian N (1999) Inherited susceptibility to aminoglycoside ototoxicity: gentic heterogenicity and clinical implications. Am J Otolaryngol 20: 151–156

    PubMed  CAS  Google Scholar 

  • Cazals Y (2000) Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol 62: 583–631

    Article  PubMed  CAS  Google Scholar 

  • Cersosimo RJ, Carter RT, Matthews SJ, Coderre M, Karp DD (1987) Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration. Drug Intell Clin Pharm 21: 798–803

    PubMed  CAS  Google Scholar 

  • Chevreau C, Thomas F, Couteau C, Dalenc F, Mourey L, Chatelut E (2005) Ototoxicity of high-dose carboplatin. J Clin Oncol 23: 3649–3650

    Article  PubMed  Google Scholar 

  • Claessen FA, van Boxtel CJ, Perenboom RM, Tange RA, Wetsteijn JC, Kager PA (1998) Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Trop Med Int Health 3: 482–489

    Article  PubMed  CAS  Google Scholar 

  • Cohen E, Dadashev A, Drucker M, Samra Z, Rubinstein E, Garty M (2002) Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. J Antimicrob Chemother 49: 155–160

    Article  PubMed  CAS  Google Scholar 

  • Cooperman LB, Rubin IL (1973) Toxicity of ethacrynic acid and furosemide. Am Heart J 85: 831–834

    Article  PubMed  CAS  Google Scholar 

  • Coulston J, Balaratnam N (2005) Irreversible sensorineural hearing loss due to clarithromycin. Postgrad Med J 81: 58–59

    Article  PubMed  CAS  Google Scholar 

  • Dautzenberg B, Piperno D, Diot P, Truffot-Pemot C, Chauvin JP (1995) Clarithromycin in the treatment of mcybacterium avium lung infections in patients without AIDS. Chest 107: 1035–1040

    PubMed  CAS  Google Scholar 

  • Ding D, McFadden SL, Woo JM, Salvi RJ (2002) Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea. Hear Res 173: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Dvorak K (1980) Hormonal contraception and hearing disorders. Cesk Gynekol 45: 653–655

    PubMed  CAS  Google Scholar 

  • East JE, Foweraker JE, Murgatroyd FD (2005) Gentamicin induced ototoxicity during treatment of enterococcal endocarditis: resolution with substitution by netilmicin. Heart 91:32

    Article  Google Scholar 

  • Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurootol 5: 3–22

    Article  PubMed  CAS  Google Scholar 

  • Formann E, Stauber R, Denk DM et al. (2004) Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 99: 873–877

    Article  PubMed  CAS  Google Scholar 

  • Gallagher KL, Jones JK (1979) Furosemide-induced ototoxicity. Ann Intern Med 91: 744–745

    PubMed  CAS  Google Scholar 

  • Garrison MW, Zaske DE, Rotschafer JC (1990) Aminoglycosides: another perspective. DICP Ann Pharmacother 24: 267–272

    CAS  Google Scholar 

  • Gerharz EW, Weingartner K, Melekos MD, Varga S, Feiber H, Riedmiller H (1995) Neomycin-induced perception deafness following bladder irrigation in patients with end-stage renal disease. Br J Urol 76: 479–481

    Article  PubMed  CAS  Google Scholar 

  • Gorur K, Kandemir O, Unal M, Ozcan C (2003) The effect of recombinant interferon alpha treatment on hearing thresholds in patients with chronic viral hepatitis B. Auris Nasus Larynx 30: 41–44

    Article  PubMed  Google Scholar 

  • Govaerts PJ, van de Heyning PH, Jorens G, Marquet J, De Broe ME (1990) Aminoglycoside induced ototoxicity. Toxicol Lett 53: 227–251

    Google Scholar 

  • Haller JT, Hardin JG (1988) Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study. Ann Rheum Dis 47: 134–137

    Google Scholar 

  • Hanna GS (1986) Sudden deafness and the contraceptive pill. J Laryngol Otol 100: 701–706

    PubMed  CAS  Google Scholar 

  • Hatala R, Rinh T, Cook DJ (1996) Once daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 124: 717–725

    PubMed  CAS  Google Scholar 

  • Hinojosa R, Nelson EG, Lemer SA, Redleaf MI, Schramm DR (2001) Aminoglycoside ototoxicity: a human temporal bone study. Laryngoscope 111: 1797–1805

    PubMed  CAS  Google Scholar 

  • Hulst RJ van der, Dreschler WA, Urbanus NA (1988) High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives. Ann Otol Rhinol Laryngol 97: 133–137

    PubMed  Google Scholar 

  • Jardini L, Findlay R, Burgi E, Hinderer K, Agarwal A (1978) Auditory changes associated with moderate blood salicylate levels. Rheumatol Rehabil 17: 233–236

    Article  PubMed  CAS  Google Scholar 

  • Kalcioglu MT, Kuku I, Kaya E, Oncel S, Aydogdu I (2003) Bilateral hearing loss during vincristine therapy: a case report. J Chemother 15: 290–292

    PubMed  CAS  Google Scholar 

  • Kalkanis JG, Whitworth C, Rybak LP (2004) Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114: 538–542

    PubMed  CAS  Google Scholar 

  • Kanda Y, Shigeno K, Kinoshita N, Nakao K, Yano M, Matsuo H (1994) Sudden hearing loss associated with interferon. Lancet 7: 1134–1135

    Google Scholar 

  • Kanda Y, Shigeno K, Matsuo H, Yano M, Yamada N, Kumagami H (1995) Interferon-induced sudden hearing loss. Audiology 34: 98–102

    PubMed  CAS  Google Scholar 

  • Kennedy IC, Fitzharris BM, Colls BM, Atkinson CH (1990) Carboplatin is ototoxic. Cancer Chemother Pharmacol 26: 232–234

    Article  PubMed  CAS  Google Scholar 

  • Klibanov OM, Filicko JE, DeSimone JA, Tice DS (2003) Sensorineural hearing loss associated with intrathecal vancomycin. Ann Pharmacother 37: 61–65

    Article  PubMed  Google Scholar 

  • Kwong DL, Wei WI, Sham JS et al. (1996) Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 36: 281–289

    Article  PubMed  CAS  Google Scholar 

  • Lautermann J, Adamczyk M, tenCate WJ, Kloke O (1998) Hearing loss caused by high dose carboplatin therapy. Laryngorhinootologie 77: 82–84

    PubMed  CAS  Google Scholar 

  • Laurell G, Beskow C, Frankendal B, Borg E (1996) Cisplatin admninistration to gynecologic cancer patients. Long-term effects on hearing. Cancer 78: 1798–1804

    Article  PubMed  CAS  Google Scholar 

  • Leyvraz S, Ohnuma T, Lassus M, Holland JF (1985) Phase I study of carboplatin in patients with advanced cancer, intermittend intravenous bolus, and 24 hour infusion. J Clin Oncol 3: 1385–1392

    PubMed  CAS  Google Scholar 

  • Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 40: 2445–2451

    Article  PubMed  CAS  Google Scholar 

  • Lind O, Harthug S (1993) Hearing loss after erythromycin therapy. Tidsskr Nor Laegeforen 113:2810–2811

    PubMed  CAS  Google Scholar 

  • Linder TE, Zwicky S, Brandle P (1995) Ototoxicity of ear drops: a clinical perspective. Am J Otol 16: 653–657

    PubMed  CAS  Google Scholar 

  • Lloyd-Mostyn RH, Lord IJ (1971) Ototoxicity of intravenous frusemide. Lancet 2: 1156

    PubMed  CAS  Google Scholar 

  • Lugassy G, Shapira A (1990) Sensorineural hearing loss associated with vincristine treatment. Blut 61: 320–321

    Article  PubMed  CAS  Google Scholar 

  • Lugassy G, Shapira A (1996) A prospective cohort study of the effect of vincristine on audition. Anticancer Drugs 7: 525–526

    PubMed  CAS  Google Scholar 

  • Mahajan SL, Ikeda Y, Myers TJ, Baldini MG (1981) Acute acoustic nerve palsy associated with vincristine therapy. Cancer 47: 2404–2406

    PubMed  CAS  Google Scholar 

  • Maher JF, Schreiner GE (1965) Studies on ethacrynic acid in patients with refractory edema. Ann Int Med 62: 15–29

    PubMed  CAS  Google Scholar 

  • Matz G, Rybak L, Roland PS et al. (2004) Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg 130: 79–82

    Article  Google Scholar 

  • McGhan LJ, Merchant SN (2003) Erythromycin ototoxicity. Otol Neurotol 24: 701–702

    PubMed  Google Scholar 

  • McRorie TI, Bosso J Randolph L (1989) Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry. Am J Dis Child 143: 1328–1332

    PubMed  CAS  Google Scholar 

  • Meyskens FL, Kingsley EM, Glattke T, Loescher L, Booth A (1986) A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Invest New Drugs 4: 257–262

    Article  PubMed  CAS  Google Scholar 

  • Mellor JA, Kingdom J, Cafferkey M, Keane C (1984) Vancomycin ototoxicity in patients with normal renal function. Br J Audiol 18: 179–180

    PubMed  CAS  Google Scholar 

  • Miller RR, Jick H (1977) Acute toxicity of aspirin in hospitalized medical patients. Am J Med Sci 274: 271–279

    PubMed  CAS  Google Scholar 

  • Moral A, Navasa M, Rimola A, Garcia-Valdecasas JC, Grande L, Visa J, Rodes J (1994) Erythromycin ototoxicity in liver transplant patients. Transpl Int 7: 62–64

    Article  PubMed  CAS  Google Scholar 

  • Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P (1999) Cisplatin ototoxicity: the importance of baseline audiometry. Am J Clin Oncol 22: 305–308

    Article  PubMed  CAS  Google Scholar 

  • Nielsen-Abbring FW, Perenboom RM, van der Hulst RJ (1990) Quinine-induced hearing loss. ORL J Otorhinolaryngol Relat Spec 52: 65–68

    PubMed  CAS  Google Scholar 

  • Oh YT, Kim CH, Choi JH, Kang SH, Chun M (2004) Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 72: 79–82

    Article  PubMed  Google Scholar 

  • Okulicz G (1978) Inner ear disturbance following long-term usage of hormonal contraceptives. HNO 26: 330–334

    PubMed  CAS  Google Scholar 

  • Parsons SK, Neault MW, Lehmann LE, Brennan LL, Eickhoff CE, Kretschmar CS, Diller LR (1998) Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 22: 669–674

    Article  PubMed  CAS  Google Scholar 

  • Peloquin CA, Berning SE, Nitta AT et al. (2004) Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis 38:1538–1544

    Article  PubMed  CAS  Google Scholar 

  • Pillay VKG, Schwartz FD, Aimi K, Kark RM (1969) Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1(7585): 77–79

    PubMed  CAS  Google Scholar 

  • Porter J, Jick H (1977) Drug induced anaphylaxis, convulsions, deafness and extrapyramidal symptoms. Lancet 1(8011): 578–578

    Google Scholar 

  • Prazma J, Thomas WG, Fischer ND, Preslar MJ (1972) Ototoxicity of ethacrynic acid. Arch Otolaryngol 95: 448–456

    PubMed  CAS  Google Scholar 

  • Ress BD, Gross EM (2000) Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. Ann Otol Rhinol Laryngol 109: 435–437

    PubMed  CAS  Google Scholar 

  • Roche RJ, Silamut K, Pukrittayakamee S, Looareesuwan S, Molunto P, Boonamrung S, White NJ (1990) Quinine induces reversible high-tone hearing loss. Br J Clin Pharmacol 29: 780–782

    PubMed  CAS  Google Scholar 

  • Rubin JS, Wadler, S, Beitler JJ et al. (1995) Audiological findings in a phase I protocol investigating the effect of WR2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma. J Laryngol Otol 109: 744–747

    PubMed  CAS  Google Scholar 

  • Rybak LP (1982) Pathophysiology of furosemide ototoxicity. J Otolaryngol 11: 127–133

    PubMed  CAS  Google Scholar 

  • Rybak LP (1993) Ototoxicity of loop diuretics. Otolaryngol Clin North Am 26: 829–844

    PubMed  CAS  Google Scholar 

  • Sacristan JA, Soto JA, Cos MA de (1993) Erythromycin-induced hypoacusis: 11 new cases and literature review. Ann Pharmacother 27: 950–955

    PubMed  CAS  Google Scholar 

  • Samani F, Bolzonello P, Fior R, Elia A (1987) Effects on hearing during prolonged oral contraceptive use. Contraception 35: 41–47

    Article  PubMed  CAS  Google Scholar 

  • Salvinelli F, Casale M, Vincenzi B et al. (2003) Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect. J Epx Clin Cancer Res 22: 155–158

    CAS  Google Scholar 

  • Schonwald S, Shannon M (1991) Unsuspected quinine intoxication presenting as acute deafness and mutism. Am J Emerg Med 9: 318–320

    Article  PubMed  CAS  Google Scholar 

  • Schwartz GH, David DS, Riggio RR, Stenzel KH, Rubin AL (1970) Ototoxicity induced by furosemide. N Engl J Med 282: 1413–1414

    PubMed  CAS  Google Scholar 

  • Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M (1996) Drug induced tinnitus and other hearing disorders. Drug Saf 14: 198–212

    Article  PubMed  CAS  Google Scholar 

  • Sluyter S, Klis SF, deGroot JC, Smoorenburg GF (2003) Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 185: 49–56

    Article  PubMed  CAS  Google Scholar 

  • Solary E, Caillot D, Chauffert B, Casasnovas RO, Dumas M, Maynadie M, Guy H (1992) Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia. J Clin Oncol 10: 1730–1736

    PubMed  CAS  Google Scholar 

  • Stohr W, Langer T, Kremers A, Bielack S, Lamprecht-Dinnesen A, Frey E, Beck JD (2005) Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system. Cancer Invest 23: 201–207

    PubMed  CAS  Google Scholar 

  • Sudaka J (1976) Cochlear deafness in women taking oral contraceptives. Nouv Presse Med 5: 2807–2808.

    PubMed  CAS  Google Scholar 

  • Swanson DJ, Sung RJ, Fine MJ, Orloff JJ, Chu Sy, Yu VL (1992) Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. Am J Med 92: 61–68

    Article  PubMed  CAS  Google Scholar 

  • Tange RA, Dreschler WA, Prins JM, Buller HR, Kuijper EJ, Speelman P (1995) Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial. Clin Otolaryngol Allied Sci 20: 118–123

    PubMed  CAS  Google Scholar 

  • Tange RA, Dreschler WA, Claessen FA, Perenboom RM (1997) Ototoxic reactions of quinine in healthy persons and patients with plasmodium falciparum infection. Auris Nasus Larynx 24: 131–136

    Article  PubMed  CAS  Google Scholar 

  • Tibaldi C, Pazzagli I, Berrettini S, DeVito A (1998) A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine. Eur J Cancer 34: 1133–1134

    Article  PubMed  CAS  Google Scholar 

  • Traber PG, Levine DP (1981) Vancomycin ototoxicity in patient with normal renal function. Ann Intern Med 95: 458–460

    PubMed  CAS  Google Scholar 

  • Tunca A, Erbayrak M, Aytac S, Turkay C (2004) Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report. Turk J Gastroenterol 15: 97–99

    PubMed  Google Scholar 

  • Vasquez EM, Maddux MS, Sanchez J, Pollak R (1993) Clinically siginficant hearing loss in renal allograft recipients treated with intravenous erythromycin. Arch Intern Med 153: 879–882

    Article  PubMed  CAS  Google Scholar 

  • Vessey M, Painter R (2001) Oral contraception and ear disease: findings in large cohort study. Contraception 63: 61–63

    Article  PubMed  CAS  Google Scholar 

  • Vogler WR, Harrington DP, Winton EF, Lazarus HM, Bennett JM, Cassileth PA, Oken MM (1992) Phase II clinical trial of carboplatin in relapsed and refractory leukemia. Leukemia 6: 1072–1075

    PubMed  CAS  Google Scholar 

  • Wecker H, Laubert A (2004) Reversible hearing loss in acute salicylate intoxication. HNO 52: 347–351

    Article  PubMed  CAS  Google Scholar 

  • Yamane H, Nakai Y, Konishi K (1988) Furosmide-induced alteration of drug pathway to cochlea. Acta Otolaryngol Suppl 447: 28–35

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik Helios-Kliniken Schwerin, Wismarsche Str. 393-397, 19049, Schwerin

    Prof. Dr. med. F. Block

Authors
  1. Prof. Dr. med. F. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Block, F. (2006). Hörstörungen. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_16

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation